Tarsons Products [TARSONS] vs RPG Life Sciences [RPGLIFE] Detailed Stock Comparison
Tarsons Products
NSE
Loading...
RPG Life Sciences
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Tarsons Products wins in 5 metrics, RPG Life Sciences wins in 15 metrics, with 0 ties. RPG Life Sciences appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Tarsons Products | RPG Life Sciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 63.35 | 21.13 | RPG Life Sciences |
| Price-to-Book Ratio | 2.76 | 7.28 | Tarsons Products |
| Debt-to-Equity Ratio | 53.82 | 0.00 | RPG Life Sciences |
| PEG Ratio | -1.16 | -12.21 | RPG Life Sciences |
| EV/EBITDA | 17.88 | 23.03 | Tarsons Products |
| Profit Margin (TTM) | 6.90% | 27.82% | RPG Life Sciences |
| Operating Margin (TTM) | 5.22% | 17.95% | RPG Life Sciences |
| EBITDA Margin (TTM) | 5.22% | 17.95% | RPG Life Sciences |
| Return on Equity | 4.72% | 34.54% | RPG Life Sciences |
| Return on Assets (TTM) | 2.76% | 27.86% | RPG Life Sciences |
| Free Cash Flow (TTM) | $-374.69M | $418.30M | RPG Life Sciences |
| Dividend Yield | 0.53% | 1.50% | RPG Life Sciences |
| 1-Year Return | -29.81% | 9.31% | RPG Life Sciences |
| Price-to-Sales Ratio (TTM) | 4.37 | 5.88 | Tarsons Products |
| Enterprise Value | $20.31B | $36.36B | RPG Life Sciences |
| EV/Revenue Ratio | 5.09 | 5.53 | Tarsons Products |
| Gross Profit Margin (TTM) | 67.93% | 64.47% | Tarsons Products |
| Revenue per Share (TTM) | $75 | $397 | RPG Life Sciences |
| Earnings per Share (Diluted) | $5.17 | $110.60 | RPG Life Sciences |
| Beta (Stock Volatility) | 0.11 | -0.37 | RPG Life Sciences |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Tarsons Products vs RPG Life Sciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Tarsons Products | -1.39% | -6.34% | -14.41% | -28.27% | 3.83% | -21.72% |
| RPG Life Sciences | 1.05% | 0.46% | 2.52% | 6.65% | 3.78% | 4.78% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Tarsons Products | -29.81% | -58.67% | -61.21% | -61.21% | -61.21% | -61.21% |
| RPG Life Sciences | 9.31% | 197.21% | 544.62% | 1,397.95% | 2,190.15% | 1,772.74% |
Performance & Financial Health Analysis: Tarsons Products vs RPG Life Sciences
| Metric | TARSONS | RPGLIFE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹17.43B | ₹38.64B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 106,122 | 9,168 |
| 90 Day Avg. Volume | 58,703 | 24,781 |
| Last Close | ₹313.05 | ₹2,325.80 |
| 52 Week Range | ₹280.00 - ₹491.80 | ₹1,835.00 - ₹2,974.95 |
| % from 52W High | -36.35% | -21.82% |
| All-Time High | ₹924.90 (Nov 29, 2021) | ₹2,974.95 (Oct 14, 2024) |
| % from All-Time High | -66.15% | -21.82% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.02% |
| Quarterly Earnings Growth | -0.56% | -0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.28% |
| Operating Margin (TTM) | 0.05% | 0.18% |
| Return on Equity (TTM) | 0.05% | 0.35% |
| Debt to Equity (MRQ) | 53.82 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹118.59 | ₹320.78 |
| Cash per Share (MRQ) | ₹4.89 | ₹159.99 |
| Operating Cash Flow (TTM) | ₹571.91M | ₹1.08B |
| Levered Free Cash Flow (TTM) | ₹297.70M | ₹1.83B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.53% | 1.50% |
| Last 12-Month Dividend | ₹2.00 | ₹36.00 |
Valuation & Enterprise Metrics Analysis: Tarsons Products vs RPG Life Sciences
| Metric | TARSONS | RPGLIFE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 63.35 | 21.13 |
| Forward P/E | 26.41 | 81.75 |
| PEG Ratio | -1.16 | -12.21 |
| Price to Sales (TTM) | 4.37 | 5.88 |
| Price to Book (MRQ) | 2.76 | 7.28 |
| Market Capitalization | ||
| Market Capitalization | ₹17.43B | ₹38.64B |
| Enterprise Value | ₹20.31B | ₹36.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.09 | 5.53 |
| Enterprise to EBITDA | 17.88 | 23.03 |
| Risk & Other Metrics | ||
| Beta | 0.11 | -0.37 |
| Book Value per Share (MRQ) | ₹118.59 | ₹320.78 |
Financial Statements Comparison: Tarsons Products vs RPG Life Sciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TARSONS | RPGLIFE |
|---|---|---|
| Revenue/Sales | ₹913.64M | ₹1.69B |
| Cost of Goods Sold | ₹293.05M | ₹600.20M |
| Gross Profit | ₹620.59M | ₹1.09B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹47.67M | ₹303.30M |
| EBITDA | ₹280.39M | ₹407.00M |
| Pre-Tax Income | ₹30.32M | ₹354.30M |
| Income Tax | ₹12.49M | ₹91.40M |
| Net Income (Profit) | ₹17.83M | ₹262.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TARSONS | RPGLIFE |
|---|---|---|
| Cash & Equivalents | ₹251.31M | ₹287.00M |
| Total Current Assets | ₹2.43B | ₹4.65B |
| Total Current Liabilities | ₹1.76B | ₹1.20B |
| Long-Term Debt | ₹2.12B | N/A |
| Total Shareholders Equity | ₹6.30B | ₹5.31B |
| Retained Earnings | N/A | ₹4.74B |
| Property, Plant & Equipment | ₹4.72B | ₹1.61B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TARSONS | RPGLIFE |
|---|---|---|
| Operating Cash Flow | ₹100.02M | N/A |
| Capital Expenditures | ₹-279.63M | N/A |
| Free Cash Flow | ₹-231.27M | N/A |
| Debt Repayment | ₹-754.90M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TARSONS | RPGLIFE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 106,122 | 9,168 |
| Average Daily Volume (90 Day) | 58,703 | 24,781 |
| Shares Outstanding | 53.21M | 16.54M |
| Float Shares | 13.20M | 4.29M |
| % Held by Insiders | 0.75% | 0.71% |
| % Held by Institutions | 0.08% | 0.09% |
Dividend Analysis & Yield Comparison: Tarsons Products vs RPG Life Sciences
| Metric | TARSONS | RPGLIFE |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | ₹36.00 |
| Last 12-Month Dividend Yield | 0.53% | 1.50% |
| 3-Year Avg Annual Dividend | ₹0.67 | ₹19.20 |
| 3-Year Avg Dividend Yield | 0.46% | 1.17% |
| 3-Year Total Dividends | ₹2.00 | ₹57.60 |
| Ex-Dividend Date | Sep 20, 2024 | Jun 27, 2025 |